Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3 3b Trials. J of Skin 2026, 10 (3), s772. https://doi.org/10.25251/pkdcct35.